Oriola Oyj (LON:0NES)

Market Cap	187.84M +29.5%
Revenue (ttm)	1.61B +13.5%
Net Income	-23.65M
EPS	-0.13
Shares Out	n/a
PE Ratio	n/a
Forward PE	11.80
Dividend	0.06 (5.10%)
Ex-Dividend Date	Apr 3, 2025

Volume	6,635
Average Volume	19,083
Open	1.170
Previous Close	1.160
Day's Range	1.170 - 1.182
52-Week Range	0.936 - 1.250
Beta	0.46
RSI	48.64
Earnings Date	Feb 25, 2026

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1907
• Employees: 801
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NES

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.

Financial numbers in EUR